NRL-03 - NEUROTECHNOLOGY
Neuralink
Restoring motor and sensory function through neural interface.
PRICE HISTORY
$223.13+1.70%
OVERVIEW
Neuralink develops implantable brain-computer interfaces designed to restore motor function and communication for people with paralysis, and is developing Blindsight, an experimental device aimed at restoring vision. The company operates through ongoing clinical trials across multiple countries.
KEY FIGURES
- Trial participants
- 12+
- Trial countries
- 4
- Latest valuation
- $9.7B
- Employees
- 650+
INVESTMENT TERMS
- Minimum investment
- $40.0k
- Maximum investment
- $60k
- Daily ROI / profits
- 10%
- Bonus earnings
- Disbursed Daily
Daily ROI accrues automatically to your investment on the dashboard. Bonus earnings are disbursed and will also reflect on your dashboard once issued.
INVEST IN NEURALINK
$40.0k – $60k
·10% DAILY ROI
$40.0k$60k
SELECTED - $40.0k